All UK babies will soon have access to a vaccine against meningitis B after a deal with drug manufacturers Health Secretary Jeremy Hunt has announced The agreement with GlaxoSmithKline will mean the vaccine can be introduced on the NHS this year Mr Hunt said Government advisers said in  that every child over two months old should be given the vaccine but negotiations over costs have delayed this process   Mr Hunt said it was important to get value for money Campaigners had warned the delays put childrens lives at risk The drug will now be added to the national childhood immunisation scheme meaning babies will receive the first vaccine at two months old followed by two further doses Scotlands health secretary Shona Robison said the vaccine would be provided to all infants in Scotland as quickly as possible following the deal  which was also made on behalf of the devolved government A Welsh government spokesman said a price for the vaccine had been negotiated and the Welsh government was committed to being included in the UKwide procurement for the vaccine and to make it available in Wales as soon as practicable Northern Irelands health minister Jim Wells also welcomed the outcome of the negotiations to secure an effective safe and costeffective vaccine Mr Hunt said he was delighted to have secured an agreement with GSK  the company that now manufactures the vaccine It followed lengthy negotiations with another supplier  Novartis  which used to own the vaccine called Bexsero GSK acquired the vaccine from Novartis which resulted in the price of the vaccine being reduced and the deal being struck Mr Hunt said  Tenyearold Sofia Crockatt lost her left leg below the knee to meningitis when she was two Despite this she has no mobility issues and runs goes horse riding and takes part in athletics Her father Nick said the day she became sick in  was one of the worst days of our life Sofia went from being ill with what looked like a regular flu bug to fighting for her life within hours The speed of it is scary We found out a year ago that the vaccine was available and was ready to go  we then celebrated a year ago that this vaccine was available Its just frustrating and disappointing that some people have lost their lives and limbs and bits and pieces as a result of this vaccine not being available Announcing the agreement the health secretary said he was very proud that we will be the first country in the world to have a nationwide MenB vaccination programme He said that although it was disappointing the deal had taken so long it was important to follow the advice of independent scientific advisors on vaccines and their costs We follow that advice because we cant afford every single medicine every single new vaccine on the NHS Mr Hunt added The deal means we can now go ahead this year with rolling out the meningitis B vaccine and I think thats something that families particularly ones with young children will really welcome Sue Davie chief executive of charity Meningitis Now said To know that babies will be protected against MenB is fantastic and another great step forward in our fight against meningitis Chris Head chief executive of the Meningitis Research Foundation said We are delighted that vaccinating all babies against this devastating disease is now within sight cementing the UKs position as a world leader in meningitis prevention Linda Glennie also of the foundation said the vaccine was predicted to cover more than  of meningitis B cases It would protect against a more virulent strain of meningitis B increasingly found in the UK she added  Meningitis B is a bacterial infection that particularly affects children under the age of one It commonly affects children under five years of age and is also common among teenagers aged  to    There are about  cases of meningitis B each year in the UK Symptoms include a high fever with cold hands and feet confusion vomiting and headaches Most children will make a full recovery with early diagnosis and antibiotic treatment It is fatal in one in  cases About one in four of those who survive is left with longterm problems such as amputation deafness epilepsy and learning difficulties